Search Medical Condition
Please enter condition
Please choose location from dropdown

Blue Bell, Pennsylvania Clinical Trials

A listing of Blue Bell, Pennsylvania clinical trials actively recruiting patient volunteers.

RESULTS

Found (207) clinical trials

Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs)

UCDs disproportionately affect children and females: depending on the severity of the defect, a UCD can manifest shortly after birth or later in life. This study will track long-term outcomes in UCD patients and effects of ammonia-scavenging agents on neuropsychological functions of UCD patients. This is a non-interventional, multi-center registry ...

Phase N/A

0.0 miles

Learn More »

Effectiveness of Physical Therapy Interventions for Low Back Pain Targeting the Low Back Only or Low Back Plus Hips

Often, individuals with LBP also have concurrent impairments in strength and/or range of motion of one or both hips. Physical therapists may or may not decide to treat the concurrent hip impairments for an individual with LBP based on their clinical decision making. Currently, it is unknown which approach leads ...

Phase N/A

0.0 miles

Learn More »

If your child has a ragweed allergy, he/she may be eligible to participate in a clinical research study to evaluate the effectiveness and safety of an investigational sub-lingual immunotherapy tablet.

Phase N/A

0.0 miles

Learn More »

Research study to evaluate the effectiveness and safety of investigational sublingual immunotherapy tablet on ragweed allergy.

Phase N/A

0.0 miles

Learn More »

A Study of the Lifting Capacity of Fillers

All fillers will be injected in locations where the FDA has approved it for on-label indications (the cheek, subcutaneously and supraperiosteally, the dermis and subdermis for the correction of wrinkles and folds such as the nasolabial fold) and placed as usual and customary using techniques as practiced by the authors ...

Phase N/A

3.45 miles

Learn More »

Lyme Test Indication Combinations (LyTIC) Study

The present study aims to investigate the performance characteristics of both established and new assays for Borrelia burgdorferi infection and to assess the relative performance of appropriate combinations of these tests. The study will also investigate the effect of the time course of the infection and its treatment on the ...

Phase N/A

3.51 miles

Learn More »

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials

This registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in being contacted for an Eli Lilly and Company (Lilly) Alzheimer's Disease drug research trial.

Phase N/A

3.51 miles

Learn More »

A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia

The main purpose of this study is to evaluate the efficacy of the study drug known as lanabecestat in participants with mild Alzheimer's disease (AD) dementia.

Phase

3.51 miles

Learn More »

Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia

STUDY SYNOPSIS Study Design Number of subjects enrolled: Forty patients (Two groups - 20 each) Number of centers: One Study design: Single-blind, Switching Paradigm Extension: None specifically, although patients who do have a good clinical response to the treatment will probably be maintained on their medication at the discretion of ...

Phase N/A

3.51 miles

Learn More »

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

PRIMARY OBJECTIVES: I. To evaluate the proportion of patients with objective response (OR) to targeted study agent(s) in patients with advanced refractory cancers/lymphomas/multiple myeloma. SECONDARY OBJECTIVES: I. To evaluate the proportion of patients alive and progression free at 6 months of treatment with targeted study agent in patients with advanced ...

Phase

3.51 miles

Learn More »